日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer

VIKTORIA-1试验:Gedatolisib联合Fulvestrant,加或不加Palbociclib治疗激素受体阳性/HER2-/PIK3CA野生型晚期乳腺癌

Hurvitz, Sara A; Layman, Rachel M; Curigliano, Giuseppe; André, Fabrice; Cristofanilli, Massimo; Kim, Sung-Bae; Martínez Rodríguez, Jorge Luis; Nadal, Jorge C; Kim, Gun Min; Lo, Louisa; Remolina-Bonilla, Yuly A; Rosselli, Geronimo; Emile, George; Korbenfeld, Ernesto; Puig, Juan Manuel; Wesolowski, Robert; Martin, Miguel; Ring, Alistair; Han, Hyo S; Giordano, Antonio; Mutka, Sarah C; Moss, Keren; Suzuki, Sam; Sullivan, Brian; Gorbatchevsky, Igor; Pistilli, Barbara

Intratumoral dendritic cell immunotherapy controls dissemination of metastasis-initiating cancer cells, even in patients with metastatic breast cancer

肿瘤内树突状细胞免疫疗法可以控制转移起始癌细胞的扩散,即使在转移性乳腺癌患者中也是如此。

Soyano, Aixa; Lee, Marie Catherine; Han, Hyo S; Aldrich, Amy; Soliman, Hatem; Olson-Mcpeek, Sy K; Balsay-Patel, Caitlyn N; Aiello, Paige; Farrell, Carly M; Weinfurtner, Robert; Burgos, Eliana; Czerniecki, Brian J; Ramamoorthi, Ganesan

A Phase II Trial to Evaluate the Safety and Immunogenicity of Two Doses of a Folate Receptor Alpha Vaccine in Patients with Triple-Negative Breast Cancer

一项评估两剂叶酸受体α疫苗在三阴性乳腺癌患者中安全性和免疫原性的II期临床试验

Knutson, Keith L; Abu-Fares, Hala; Keating, Patricia; Block, Matthew S; Norton, Nadine; Erskine, Courtney L; Cogen, Davitte; Assad, Hadeel; Graff, Stephanie L; Hamilton, Erika P; Han, Hyo S; McIntyre, Kristi J; Nassar, Aziza; Sparano, Joseph A; Tiersten, Amy; Tkaczuk, Katherine H; Ward, Patrick J; Wilson, Glynn; Garrett, Gerald; Kenney, Richard T; Sharma, Priyanka

Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer: A Nonrandomized Clinical Trial

ERBB2乳腺癌化疗前肿瘤内树突状细胞对肿瘤微环境的改变:一项非随机临床试验

Han, Hyo S; Aldrich, Amy L; Garg, Saurabh K; Weinfurtner, R Jared; Nguyen, Jonathan V; Mo, Qianxing; Whiting, Junmin; Childress, Jennifer; Soliman, Hatem; Costa, Ricardo; Armaghani, Avan; Soyano, Aixa; Kiluk, John; Hoover, Susan; Lee, Marie C; Khakpour, Nazanin; Shenoi, Nithin; Jameel, Zena; Koski, Gary K; Czerniecki, Brian J

Cancer-Related Cognitive Impairment and the Potential of Dietary Interventions for the Prevention and Mitigation of Neurodegeneration

癌症相关认知障碍及饮食干预在预防和缓解神经退行性疾病中的潜力

Crowder, Sylvia L; Gudenkauf, Lisa M; Hoogland, Aasha I; Han, Hyo S; Small, Brent J; Carson, Tiffany L; Parker, Nathan H; Booth-Jones, Margaret; Jim, Heather S L

Phase II trial of brain MRI surveillance in stage IV breast cancer

IV期乳腺癌脑部MRI监测的II期试验

Ahmed, Kamran A; Kim, Youngchul; Armaghani, Avan J; Arrington, John A; Costa, Ricardo L; Czerniecki, Brian J; Diaz, Roberto; Dowell, Robin A; Extermann, Martine; Forsyth, Peter A; Lee, Kimberley T; Loftus, Loretta; Mills, Matthew N; Phuoc, Vania H; Rosa, Marilin; Soliman, Hatem H; Sam, Christine S; Washington, Iman R; Soyano, Aixa E; Han, Hyo S

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer.

从临床到实验室的转化分析:激素受体阳性转移性乳腺癌中 NF1 改变和 CDK4/6 抑制剂耐药性

Lloyd Maxwell R, Chica-Parrado Rosario, Weipert Caroline M, Knepper Todd C, Podany Emily L, Napolitano Fabiana, Ye Dan, Lin Chang-Ching, Uemoto Yasuaki, Liao Jiemin, Wegrzyn Claire, Walko Christine M, Ryan Lianne Y, Keenan Jennifer C, Medford Arielle J, Liu Shiyuan A, Wulf Gerburg M, Clifton Katherine K, Ma Cynthia X, Han Hyo S, Zhang Nicole, Ellisen Leif W, Bardia Aditya, Arteaga Carlos L, Hanker Ariella B, Wander Seth A

Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study

纳武利尤单抗联合立体定向放射外科治疗乳腺癌脑转移患者:一项非随机、开放标签的 Ib 期研究的长期结果和生物标志物分析

Ahmed, Kamran A; Kim, Younchul; Kim, Sungjune; Wang, Min Hsuan; DeJesus, Michelle; Arrington, John A; Soyano, Aixa E; Armaghani, Avan J; Costa, Ricardo L B; Loftus, Loretta S; Rosa, Marilin; Caudell, Jimmy J; Diaz, Roberto; Etame, Arnold B; Tran, Nam D; Soliman, Hatem; Czerniecki, Brian J; Forsyth, Peter A; Yu, Hsiang-Hsuan Michael; Han, Hyo S

Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

格达托利西布联合帕博西尼和来曲唑治疗既往未接受过全身治疗的激素受体阳性、HER2阴性晚期乳腺癌患者

Wesolowski, Robert; Rugo, Hope S; Specht, Jennifer M; Han, Hyo S; Kabos, Peter; Vaishampayan, Ulka; Wander, Seth A; Gogineni, Keerthi; Spira, Alexander; Schott, Anne F; Abu-Khalaf, Maysa; Mutka, Sarah C; Suzuki, Samuel; Sullivan, Brian; Gorbatchevsky, Igor; Layman, Rachel M

Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer

在针对早期乳腺癌的适应性随机 I-SPY2 试验中,Pexidartinib 和标准新辅助疗法

Rugo, Hope S; Campbell, Mike; Yau, Christina; Jo Chien, A; Wallace, Anne M; Isaacs, Claudine; Boughey, Judy C; Han, Hyo S; Buxton, Meredith; Clennell, Julia L; Asare, Smita M; Steeg, Katherine; Wilson, Amy; Singhrao, Ruby; Matthews, Jeffrey B; Perlmutter, Jane; Fraser Symmans, W; Hylton, Nola M; DeMichele, Angela M; Yee, Douglas; Van't Veer, Laura J; Berry, Donald A; Esserman, Laura J